The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

Emma Walmsley was the first woman to hold the CEO post at the Big Pharma company.

GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US President Donald Trump’s administration, according to Emma Walmsley, the outgoing chief executive officer ...

The company said it will use the funds to expand its technology portfolio in AI processor design, system design, and AI ...

Central Pennsylvania is part of GSK ‘s recent announcement that it is investing $30 billion in R&D and manufacturing in the ...

Wall Street ticked higher as technology stocks recovered some of their losses from last week. The S&P 500 added 0.3% Monday.

Emma Walmsley has overseen eight turbulent years at he U.K. drugmaker. The firm announced Monday that she will be succeeded ...

GSK plc names new CEO as shares rise 3% and maintains a 4% dividend yield; get key insights on GSK stock's outlook and what ...

The move caps Walmsley's over eight years in the role that made her the most senior female CEO in the UK. She drove the ...

The shares of GlaxoSmithKline ($GSK) cheered on Monday after the British pharmaceutical giant announced that its chief ...

GSK announced that Luke Miels, the company’s chief commercial officer, will take over as CEO on Jan. 1, replacing Emma ...